Literature DB >> 31954905

Deep Brain Stimulation for the Treatment of Dopa-Responsive Dystonia: A Case Report and Literature Review.

Wenwen Dong1, Bei Luo1, Chang Qiu1, Xu Jiang2, Xuefeng Qu1, Li Zhang2, Weiguo Liu3, Jun Yan2, Wenbin Zhang4.   

Abstract

BACKGROUND: The aim of this study was to observe the improvement in patients with dopa-responsive dystonia (DRD) after deep brain stimulation (DBS) of the globus pallidus internus (GPi). CASE DESCRIPTION: A 27-year-old woman with a 22-year history of DRD underwent GPi DBS. The Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS), the Mini-Mental State Examination (MMSE), the Montreal Cognitive Assessment (MoCA), the Hamilton Anxiety Scale (HAMA), and the Hamilton Depression Scale (HAMD) were used to regularly assess changes in the patient's condition after DBS treatment.
CONCLUSIONS: After 6 months of GPi DBS treatment, the total BFMDRS score of the patient was 5, a 94.28% improvement over the preoperative baseline score. In addition, the MMSE, MOCA, HAMA, and HAMD scores of the patient were 30, 30, 1, and 2, respectively. Intelligence and cognitive levels of the patient did not change significantly compared with the preoperative baseline level, whereas anxiety and depression status of the patient improved compared with the preoperative status. GPi DBS treatment can significantly improve the symptoms of systemic dystonia in patients with DRD, and to a certain extent improve the anxiety and depression status of these patients. Therefore, we conclude that GPi DBS is an alternative safe and effective treatment for patients with DRD.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Deep brain stimulation; Dopa-responsive dystonia; Globus pallidus internus

Year:  2020        PMID: 31954905     DOI: 10.1016/j.wneu.2020.01.032

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  2 in total

Review 1.  Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.

Authors:  Ian O Bledsoe; Aaron C Viser; Marta San Luciano
Journal:  Neurotherapeutics       Date:  2020-10-23       Impact factor: 7.620

2.  Case Report: Clinical Outcome From Pallidal Stimulation in a Patient With Levodopa-Resistant Dopa-Responsive Dystonia.

Authors:  Xue Wang; Shanshan Mei; Zichen Tian; Lin Wang; Guiliang Hao; Xin Zhu; Wei Mao; Jianyu Li
Journal:  Front Neurol       Date:  2022-06-06       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.